0,1,2,3,4,5,6,7,8
,,,Table 6. Phage substrate analysis of the HIV-1 protease cleavage specificity.,,,,,
,,,Natural substrates,Selected,Kcat/Km,,,
Target,Library,Biopanning,,,,Derived Inhibitors,KI (nM),Reference
,,,P4-P3-P2-P1--P1'-P2'-P3'-P4',substrates,(μM−1s−1),,,
,,5 rounds with,,,,,,
,,,,GSGIF↓LETSL,1.3,,5,
,,progressive,,,,GSGIFΨ(CH2NH)LETSL,,
,,,,GSGVF↓VEMPL,3.9,,18,
HIV-1,,decrease of the,,,,GSGVFΨ(CH2NH)VEMPL,,
,,,,GSGVF↓VVNGL,18,,100,[199]
protease Q7K,,protease,,,,GSGVFΨ(CH2NH)VVNGL,,
,,,,GSGLF↓TEYGL,0.002,,200,
,,concentration and,,,,GSGLFΨ(CH2NH)TEYGL,,
,,,,IRKIL↓FLDG,0.002,,,
,,contact time,,,,,,
,,,,,,,IC50,
,,,(RT/IN) RKIL↓FLDG,,Protease,,,
,,,,SGNF↓VVNGLVK,,,(nM),
,Random,,(MA/CA) SQNY↓PIVQN,,,,,
,,,,KSGVF↓VENGLVK,HIV-1 only,,,
,hexapeptides,,(CA/P2) ARVL↓AEAM,,,,,
,,,,KSGVF↓VQNGLVK,HIV-1 only,,,
,fused to the,,(P2/NC) ATIM↓MQRG,,,,,
,,,,KSGNFVVN↓GLVK,HIV-1 only,,,
,MAb 3-E7,,(P1/P6) PQNF↓LQSR,,,,,
,,,,KSGV↓SVNGK,FIV only,,,
,epitope and,4 rounds with,(in P6) KELY↓PLTS,,,,,
,,,,KSGVFHVN↓GLVK,FIV only,,,
,displayed on Fd,progressive,(TF/PR) SFNF↓PQIT,,,,,
HIV-1/FIV,,,,KSGVFQVN↓GLVK,FIV only,GSGVF Ψ(CH2OH)VVNGL,HIV/FIV,
,phage,decrease of the,(PR/RT) TLNF↓YVDG,,,,,[198]
proteases,,,,KSGVF↓VVNGLVK,FIV only,GSGVF Ψ(CH2NH)VVNGL,160/5000,
,,protease,(in RT) AETF↓YVDG,,,,,
,,,,KSFVF↓VVNGLVK,HIV-1/FIV,,700/400,
,,concentration,,,,,,
,,,,KSGIF↓VVNGLVK,HIV-1/FIV,,,
,,,,KSGVF↓HVNGK,HIV-1/FIV,,,
,,,,KSGVF↓QVNGLVK,HIV-1/FIV,,,
,,,,KSGVF↓VVQGLVK,HIV-1/FIV,,,
,,,,KSGVF↓VVTGLVK,HIV-1/FIV,,,
,,,,,HIV-1/FIV,,,
,Arrow  denotes  cleavage  sites  in  the  natural  or  the  selected  substrates  sequences.  Underlined  substrates  correspond  to  sequences  used  to  derived  inhibitors.  Italic  sequences,,,,,,,
